FDA Inspection
Liquipak Corp.Liquipak Corp. – FDA Inspection, Oct 16, 2025
Record Details
This FDA Inspection record concerns Liquipak Corp., with an inspection on October 16, 2025, issued by the Detroit District Office, covering human drugs.
- Office
- Detroit District Office
- Person
View Company Profile
ID · a5d487a0-1edf-4f55-b357-04d3e9ca72e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1287196
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.180(e)(2)Items to cover on annual reviews
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Liquipak Corp.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Liquipak Corp.
- FDA Inspection 1070634 - 2018-11-01
- FDA Inspection 860780 - 2013-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.